Current status: 957 hESC lines, 5362 hiPSC lines, and 131 clinical studies, and 1898 certificates
Monthly statistic from Jan 1, 2024
Posted on January 1, 2024
| total lines | 6319 |
| hESC lines | 957 |
| hiPSC lines | 5362 |
| derivation countries | 46 |
| projects | 282 |
| providers | 874 |
| clinical studies | 131 |
| subclones | 2461 |
| certificates | 1898 |
| cell line certificates | 1754 |
| project certificates | 144 |